| Nadra N Khan, MD | |
|
2001 Medical Parkway, Acute Care Pavilion, Annapolis, MD 21401-3280 | |
| (443) 481-1000 | |
| (443) 481-1687 |
| Full Name | Nadra N Khan |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 41 Years |
| Location | 2001 Medical Parkway, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053463893 | NPI | - | NPPES |
| 012318800 | Medicaid | MD | |
| 6875055 | Other | AETNA HMO | |
| 89372202 | Other | CAREFORST MARYLAND | |
| S3990054 | Other | CAREFIRST/BLUE CHOICE | |
| 0039732900 | Other | FEDERAL BLACK LUNG | |
| 7631246 | Other | AETNA PPO | |
| 145724700 | Other | FEDERAL WRKMAN'S COMP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | D65156 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Luminis Health Medical Group, Llc | 2860447315 | 431 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Jordan Hospital is pleased to announce that it has received approval from the Massachusetts Department of Public Health for the opening of its new, state-of-the-art Wound Healing and Hyperbaric Center located on the hospital campus in Plymouth, Mass. The Wound Center features the only hospital-based hyperbaric treatment chamber in the greater Plymouth and Cape Cod region. The new Wound Center provides individuals with chronic, non-healing wounds, a local option for wound care and hyperbaric therapy.
ImThera Medical, Inc. today announced interim results from its OSA European clinical study. For the study, ten patients have been surgically implanted with ImThera's aura6000 hypoglossal nerve neurostimulation device for treating Obstructive Sleep Apnea. The target population for ImThera's neurostimulation device is moderate and severe OSA patients who are non-compliant with or cannot tolerate Continuous Positive Airway Pressure.
NYU Langone Medical Center will lead a new clinical initiative - funded by a $225,000 grant from The National Institutes of Health - to determine a breath test's effectivness to identify volatile organic compounds (VOCs) in human breath that are biomarkers of chronic obstrutive pulmonary disease (COPD).
› Verified 3 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Jordan Hospital is pleased to announce that it has received approval from the Massachusetts Department of Public Health for the opening of its new, state-of-the-art Wound Healing and Hyperbaric Center located on the hospital campus in Plymouth, Mass. The Wound Center features the only hospital-based hyperbaric treatment chamber in the greater Plymouth and Cape Cod region. The new Wound Center provides individuals with chronic, non-healing wounds, a local option for wound care and hyperbaric therapy.
ImThera Medical, Inc. today announced interim results from its OSA European clinical study. For the study, ten patients have been surgically implanted with ImThera's aura6000 hypoglossal nerve neurostimulation device for treating Obstructive Sleep Apnea. The target population for ImThera's neurostimulation device is moderate and severe OSA patients who are non-compliant with or cannot tolerate Continuous Positive Airway Pressure.
NYU Langone Medical Center will lead a new clinical initiative - funded by a $225,000 grant from The National Institutes of Health - to determine a breath test's effectivness to identify volatile organic compounds (VOCs) in human breath that are biomarkers of chronic obstrutive pulmonary disease (COPD).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nadra N Khan, MD P.o. Box 64916, Baltimore, MD 21264-4916 Ph: (443) 481-6482 | Nadra N Khan, MD 2001 Medical Parkway, Acute Care Pavilion, Annapolis, MD 21401-3280 Ph: (443) 481-1000 |
News Archive
For microbiology culture media specialist Lab M, Medica 2013 will see the international debut of µPREP™ - a brand new cost-effective line of bagged, sterile dehydrated culture media that is designed for fast, efficient and convenient reconstitution.
Jordan Hospital is pleased to announce that it has received approval from the Massachusetts Department of Public Health for the opening of its new, state-of-the-art Wound Healing and Hyperbaric Center located on the hospital campus in Plymouth, Mass. The Wound Center features the only hospital-based hyperbaric treatment chamber in the greater Plymouth and Cape Cod region. The new Wound Center provides individuals with chronic, non-healing wounds, a local option for wound care and hyperbaric therapy.
ImThera Medical, Inc. today announced interim results from its OSA European clinical study. For the study, ten patients have been surgically implanted with ImThera's aura6000 hypoglossal nerve neurostimulation device for treating Obstructive Sleep Apnea. The target population for ImThera's neurostimulation device is moderate and severe OSA patients who are non-compliant with or cannot tolerate Continuous Positive Airway Pressure.
NYU Langone Medical Center will lead a new clinical initiative - funded by a $225,000 grant from The National Institutes of Health - to determine a breath test's effectivness to identify volatile organic compounds (VOCs) in human breath that are biomarkers of chronic obstrutive pulmonary disease (COPD).
› Verified 3 days ago
Gashaw Adugna Dadi, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 240-495-4189 | |
Dr. Eugene Thomas Manion, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 900 Bestgate Road, Suite 303, Annapolis, MD 21401 Phone: 410-224-8220 Fax: 410-841-2482 | |
Dr. Lisa A Dimarzio, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Parkway, Suite 100, Annapolis, MD 21401 Phone: 410-573-1110 Fax: 410-266-0714 | |
Dr. Richard A Bernstein, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 133 Defense Hwy, Suite 109, Annapolis, MD 21401 Phone: 401-224-5558 Fax: 410-224-7321 | |
Dr. Jonathan A Altschuler, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Ste 500, Annapolis, MD 21401 Phone: 410-573-6480 Fax: 410-573-9413 | |
Dr. Ira M Weinstein, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Pkwy, Suite 607, Annapolis, MD 21401 Phone: 410-266-1644 Fax: 410-266-1642 | |
Dr. James M Blake, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 820 Bestgate Road, Suite 2a, Annapolis, MD 21401 Phone: 410-224-2116 Fax: 410-224-2118 |